ATC codes:
A04AA01
EMLc
Indication
Nausea or vomiting
ICD11 code:
MG10
INN
Ondansetron
Medicine type
Chemical agent
List type
Core
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
2 mg per mL in 2 mL ampoule (as hydrochloride dihydrate) ;
2 mg per mL in 4 mL ampoule
Oral > Liquid: 4 mg per 5 mL (as hydrochloride dihydrate)
Oral > Solid > dosage form: 4 mg (as hydrochloride dihydrate) ; 8 mg (as hydrochloride dihydrate) ; 24 mg (as hydrochloride dihydrate) (EML)
Oral > Liquid: 4 mg per 5 mL (as hydrochloride dihydrate)
Oral > Solid > dosage form: 4 mg (as hydrochloride dihydrate) ; 8 mg (as hydrochloride dihydrate) ; 24 mg (as hydrochloride dihydrate) (EML)
EML status history
Sex
All
Age
Also recommended for children
Age restriction
> 1 month
Therapeutic alternatives
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of ondansetron injection 2 mg/mL in 4 mL ampoule to the EML and EMLc;
- to modify the formulation descriptions to better describe the available dosage forms.